Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1

NCT06308978

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

This is a phase 1 study designed to evaluate the safety, pharmacokinetics (PK), and anti-B-cell activity of FT819 following treatment with or without auxiliary…

United States244 participantsStarted 2024-03-28

Treatment: FT819, Fludarabine

Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

All recent trials (1 shown)